BackImmuPharma PLC Overview

ImmuPharma PLC Current Cash

Track ImmuPharma PLC's current cash ($700K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$695836.00
↑ 75.43% YoYΔ $299188.00 vs prior year quarter

Peer trimmed avg / median

Loading

ImmuPharma PLC Current Cash History

Loading

ImmuPharma PLC vs. peers: Current Cash Comparison

Loading

ImmuPharma PLC Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

ImmuPharma PLC (IMM.L) FAQ

ImmuPharma PLC's current cash stands at $700K as of June 2026. That compares with $400K in the prior-year period — up 75.4% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

ImmuPharma PLC reported $700K in current cash versus $400K a year earlier — a 75.4% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $400K in the prior-year period — up 75.4% year over year. Sustained growth in current cash can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how ImmuPharma PLC's current cash evolved across reporting periods, while the comparison chart places IMM.L next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, current cash is commonly used to spot outliers. ImmuPharma PLC's reading of $700K is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.

Questions & Answers